Foster City, CA, United States of America

Yongli Su

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 17.8

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: The Innovative Journey of Inventor Yongli Su

Introduction

Yongli Su, an accomplished inventor based in Foster City, CA, holds an impressive portfolio of seven patents. His innovative work primarily focuses on the development of compounds aimed at treating various diseases, including cancer and immune-related disorders. Su's research contributions reflect his commitment to advancing therapeutic solutions in the medical field.

Latest Patents

Yongli Su's latest patents encompass groundbreaking compounds designed to inhibit specific pathways involved in disease progression. One of his notable inventions involves inhibitors of ARG1 and/or ARG2, which are compounds that target at least one of these arginases. The invention not only describes the synthesis of these compounds but also their applications in treating a wide range of disorders, particularly those linked to cancer and immune responses mediated by ARG1 and ARG2.

Another significant patent features tetralin and tetrahydroquinoline compounds that act as inhibitors of HIF-2α. Similar to his previous work, this invention outlines the synthesis of these compounds and their potential use in treating diverse diseases, with a particular focus on immune-related conditions.

Career Highlights

Throughout his career, Yongli Su has made substantial contributions while working at prominent biotechnology companies. His experience at Arcus Biosciences, Inc. and Amgen Inc. has provided him with a strong foundation in the science and technology behind drug development. These roles have allowed him to translate his innovative ideas into practical solutions for pressing medical challenges.

Collaborations

In his journey, Su has had the opportunity to collaborate with notable individuals in the field, including Joel Worley Beatty and Tezcan Guney. Working alongside such talented coworkers has undoubtedly enriched his research experience and fostered a creative environment conducive to innovation.

Conclusion

Yongli Su's dedication to innovation in the biotechnology sector has led to invaluable advancements in therapeutic compounds. With his extensive background and commitment to addressing significant health issues, Su continues to inspire future generations of inventors and researchers. His work exemplifies the vital role that innovation plays in transforming lives through groundbreaking discoveries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…